XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Revenue $ 493,688 $ 521,334 $ 502,260
Operating expenses:      
Cost of revenue, excluding depreciation and amortization of intangible assets 113,756 118,628 122,946
Research and development 191,352 222,833 216,355
Selling, general and administrative 218,106 233,403 217,402
Depreciation expense 12,638 16,645 20,501
Amortization expense 43,376 57,752 62,209
Goodwill impairment     604,555
Impairment of long-lived assets 1,535 1,710 7,724
Total operating expenses 580,763 650,971 1,251,692
Operating loss (87,075) (129,637) (749,432)
Interest and other income, net 829 2,991 3,327
Interest expense - debt (3,008) (3,000) (1,512)
Gain on divestiture 100,833    
Income (loss) before taxes 11,579 (129,646) (747,617)
Provision for income taxes 12,448 10,042 13,589
Net loss (869) (139,688) (761,206)
Less: net income (loss) attributable to noncontrolling interest 13,139 (3,075) (3,722)
Net loss attributable to the Company $ (14,008) $ (136,613) $ (757,484)
Loss per share attributable to the Company:      
Basic loss per share $ (0.31) $ (3.18) $ (18.02)
Diluted loss per share $ (0.31) $ (3.18) $ (18.02)
Weighted-average number of shares used in computing net loss per share attributable to the Company - basic 45,057 43,012 42,029
Weighted-average number of shares used in computing net loss per share attributable to the Company - diluted 45,057 43,012 42,029